Adding a special diet to inflammatory bowel disease medication

This trial is testing whether the Crohn's Disease Exclusion Diet (CDED)—a structured eating plan that removes certain foods—combined with anti-TNF medication (infliximab, adalimumab, or golimumab) can be more effective at controlling inflammatory bowel disease than medication alone. Researchers want to see if this combination helps people achieve remission faster and feel better overall.

While this medication works well for many people with inflammatory bowel disease, some patients don't respond well enough or lose benefits over time. This trial is exploring whether a specific dietary approach might strengthen the medication's effectiveness and improve your chances of remission.